Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3
US-9931341-B2 · Apr 3, 2018 · US
Assitance Publique Hopitaux De Paris was listed as an assignee on 1 patent publication in 2018.
| Metric | Value |
|---|---|
| Company | Assitance Publique Hopitaux De Paris |
| Year | 2018 |
| Patents | 1 |
Representative publications for Assitance Publique Hopitaux De Paris in 2018.
Most common classification codes for Assitance Publique Hopitaux De Paris in 2018.
| CPC | Patents |
|---|---|
| A61K31/506 | 1 |
| A61K31/519 | 1 |
| A61K38/177 | 1 |
| A61K38/179 | 1 |
| A61P19/00 | 1 |
Navigate to parent entity pages.